The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat

Last updated: September 14, 2022
Sponsor: Konya Meram State Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05520021
351507
  • Ages 18-38
  • Female
  • Accepts Healthy Volunteers

Study Summary

Comparison of the effects of Nifedipine and MgSO4 therapies on maternal and fetal blood flow.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • pregnancies with preterm labor threat between 28-34 weeks gestational ages

Exclusion

Exclusion Criteria:

  • Cervical dilatation at > 4 cm and/or cervical effacement >80%,
  • Multiple pregnancies,
  • Pregnancy complications including preeclampsia, ablatio placenta, intrauterine growthrestriction, placenta previa, gestational diabetes

Study Design

Total Participants: 30
Study Start date:
September 01, 2022
Estimated Completion Date:
March 31, 2023

Study Description

In this study, the investigators aim to compare the effect of Nifedipine and MgSO4 therapies on Doppler parameters of the uterine, umbilical, middle cerebral arteries, and ductus venous in the first 48 hours of therapy in pregnancies with preterm labor threat and also compare perinatal outcomes after delivery between the groups.

Connect with a study center

  • Hasan Ali Inal

    Antalya, 07070
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.